Infanrix hexa
- Licence status
- Active substances
- Tetanus toxoid, Conjugate of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid, Pertactin (69 kda outer membrane protein - prn), Diphtheria toxoid (d), Inactivated polio virus type 2, R-dna hepatitis b surface antigen (hbsag), Inactivated polio virus type 1, Pertussis toxoid, Inactivated polio virus type 3, Filamentous haemagglutinin
- Dosage Form
- Powder and suspension for suspension for injection
- Licence number
- EU/1/00/152/19-20
- Licence holder
- GlaxoSmithKline Biologicals S.A.
Product documents
Licence information
- ATC code
- J07CA Bacterial and viral vaccines, combined, J07CA09 diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued